abstract |
Phenyltetrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof are plasma kallikrein inhibitors useful for the treatment of eye diseases, especially for the treatment of diabetic macular edema, age-related macular degeneration and choroidal angiogenesis. |